EcoDrugPlus

Opioid Receptor Kappa 1

Ensembl ID : ENSNGAG00000018928
Gene Symbol: OPRK1
3 Cross references
262 Possible Orthologues:

Opioid Receptor, Mu 1

Ensembl ID : ENSNGAG00000007044
Gene Symbol: OPRM1
1 Cross references
214 Possible Orthologues:

Opioid Related Nociceptin Receptor 1

Ensembl ID : ENSNGAG00000010506
Gene Symbol: OPRL1
3 Cross references
199 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSNGAG00000023128
Gene Symbol: OXTR
3 Cross references
262 Possible Orthologues:

P21 (Rac1) Activated Kinase 4

Ensembl ID : ENSNGAG00000016690
Gene Symbol: PAK4
3 Cross references
163 Possible Orthologues:

Pancreatic Triacylglycerol Lipase

Ensembl ID : ENSNGAG00000001135
Gene Symbol: LOC103743105
3 Cross references
291 Possible Orthologues:

Parathyroid Hormone 1 Receptor

Ensembl ID : ENSNGAG00000024079
Gene Symbol: PTH1R
3 Cross references
196 Possible Orthologues:

Peptidyl-Prolyl Cis-Trans Isomerase A

Ensembl ID : ENSNGAG00000005030
Gene Symbol: LOC103746527
2 Cross references
288 Possible Orthologues:

Peptidylprolyl Isomerase A

Ensembl ID : ENSNGAG00000018529
Gene Symbol: PPIA
2 Cross references
288 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Alpha

Ensembl ID : ENSNGAG00000004603
Gene Symbol: PPARA
3 Cross references
453 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Delta

Ensembl ID : ENSNGAG00000000295
Gene Symbol: PPARD
3 Cross references
418 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Gamma

Ensembl ID : ENSNGAG00000014683
Gene Symbol: PPARG
1 Cross references
405 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).